196 related articles for article (PubMed ID: 12231079)
1. Debulking and stenting versus debulking only of coronary artery disease in patients treated with cilostazol (final results of ESPRIT).
Tsuchikane E; Kobayashi T; Kobayashi T; Takeda Y; Otsuji S; Sakurai M; Awata N
Am J Cardiol; 2002 Sep; 90(6):573-8. PubMed ID: 12231079
[TBL] [Abstract][Full Text] [Related]
2. Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS.
Tsuchikane E; Takeda Y; Nasu K; Awata N; Kobayashi T
Catheter Cardiovasc Interv; 2004 Sep; 63(1):44-51. PubMed ID: 15343566
[TBL] [Abstract][Full Text] [Related]
3. Final results of the STent versus directional coronary Atherectomy Randomized Trial (START).
Tsuchikane E; Sumitsuji S; Awata N; Nakamura T; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Kobayashi T
J Am Coll Cardiol; 1999 Oct; 34(4):1050-7. PubMed ID: 10520789
[TBL] [Abstract][Full Text] [Related]
4. Effect of plaque debulking before stent implantation on in-stent neointimal proliferation: a serial 3-dimensional intravascular ultrasound study.
Takeda Y; Tsuchikane E; Kobayashi T; Terai K; Kobayashi Y; Nakagawa T; Sakurai M; Awata N; Kobayashi T
Am Heart J; 2003 Jul; 146(1):175-82. PubMed ID: 12851628
[TBL] [Abstract][Full Text] [Related]
5. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Tanabe Y; Ito E; Nakagawa I; Suzuki K
Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of debulking followed by stenting versus stenting alone for ostial left anterior descending artery stenosis: intravascular ultrasound guidance.
Kim YH; Hong MK; Lee SW; Lee CW; Han KH; Kim JJ; Park SW; Mintz GS; Park SJ
Am Heart J; 2004 Oct; 148(4):663-9. PubMed ID: 15459598
[TBL] [Abstract][Full Text] [Related]
8. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.
Ge J; Han Y; Jiang H; Sun B; Chen J; Zhang S; Du Z;
J Cardiovasc Pharmacol; 2005 Aug; 46(2):162-6. PubMed ID: 16044027
[TBL] [Abstract][Full Text] [Related]
9. Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
Zuliani Mauro MF; Mangione JA; Costa JR; Costa R; Piva E Mattos LA; Staico R; Feres F; Siqueira D; Sousa A; Abizaid A
J Invasive Cardiol; 2017 Mar; 29(3):76-81. PubMed ID: 28255102
[TBL] [Abstract][Full Text] [Related]
10. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
Min PK; Jung JH; Ko YG; Choi D; Jang Y; Shim WH
Circ J; 2007 Nov; 71(11):1685-90. PubMed ID: 17965485
[TBL] [Abstract][Full Text] [Related]
11. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing.
Stankovic G; Colombo A; Bersin R; Popma J; Sharma S; Cannon LA; Gordon P; Nukta D; Braden G; Collins M;
Am J Cardiol; 2004 Apr; 93(8):953-8. PubMed ID: 15081434
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
[TBL] [Abstract][Full Text] [Related]
13. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
[TBL] [Abstract][Full Text] [Related]
14. Stenting after directional coronary atherectomy compared with directional coronary atherectomy alone and stenting alone: a serial intravascular ultrasound study.
Kawamura A; Asakura Y; Ishikawa S; Okabe T; Yamane A; Li HC; Ogawa S
Circ J; 2004 May; 68(5):455-61. PubMed ID: 15118288
[TBL] [Abstract][Full Text] [Related]
15. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
Hong MK; Mintz GS; Lee CW; Kim YH; Lee SW; Song JM; Han KH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
Circulation; 2004 Feb; 109(7):881-6. PubMed ID: 14967732
[TBL] [Abstract][Full Text] [Related]
16. Effects of cilostazol on angiographic restenosis after coronary stent placement.
Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
[TBL] [Abstract][Full Text] [Related]
17. Clinical and angiographic outcome of directional atherectomy followed by stent implantation in de novo lesions located at the ostium of the left anterior descending coronary artery.
Airoldi F; Di Mario C; Stankovic G; Briguori C; Carlino M; Chieffo A; Liistro F; Montorfano M; Pagnotta P; Spanos V; Tavano D; Colombo A
Heart; 2003 Sep; 89(9):1050-4. PubMed ID: 12923025
[TBL] [Abstract][Full Text] [Related]
18. Impact of cilostazol on intimal proliferation after directional coronary atherectomy.
Tsuchikane E; Katoh O; Sumitsuji S; Fukuhara A; Funamoto M; Otsuji S; Tateyama H; Awata N; Kobayashi T
Am Heart J; 1998 Mar; 135(3):495-502. PubMed ID: 9506336
[TBL] [Abstract][Full Text] [Related]
19. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.
Inoue T; Uchida T; Sakuma M; Imoto Y; Ozeki Y; Ozaki Y; Hikichi Y; Node K
J Am Coll Cardiol; 2004 Oct; 44(7):1408-14. PubMed ID: 15464320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
